CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Colin Walsh, Matthew Baker |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 17.50p |
Change Today | 0.50p |
% Change | 2.94 % |
52 Week High | 17.90 |
52 Week Low | 2.95 |
Volume | 1,611,676 |
Shares Issued | 113.66m |
Market Cap | £19.89m |
Beta | 0.01 |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:29 | 79,514 @ 17.60p |
16:13 | 100,000 @ 17.10p |
16:07 | 55,605 @ 17.70p |
16:29 | 4 @ 17.70p |
16:29 | 206 @ 17.62p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research